๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX ยท Real-Time Price ยท USD
1.510
-0.100 (-6.21%)
Nov 19, 2026, 4:00 PM EST - Market closed

Polaryx Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Operating Income
-7.58-7.82-4.35-3.78
Net Income
-8.75-8.99-30.36-3.78
Earnings Per Share
-0.18-0.20-0.89-0.35
EPS Growth
----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Cash & Investments
8.445.144.620
Total Debt
---0.13
Net Cash (Debt)
8.445.144.62-0.13
Net Cash Growth
46.91%11.30%--
Net Cash Per Share
0.180.110.14-0.01

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-8.02-3.94-2.57-0.17
Free Cash Flow
-8.02-3.94-2.57-0.17
Free Cash Flow Growth
----